09:56 AM EST - Valeant Pharmaceuticals International, Inc. : announced today that Valeant and its subsidiary, Valeant International (Barbados) SRL (VIB), have signed an agreement to acquire Dermik, a dermatology unit of Sanofi in the U.S. and Canada, as well as the worldwide* rights to Sculptra® Aesthetic (injectable poly-L-lactic acid). Valeant Pharmaceuticals International, Inc.
shares T.VRX are trading down $0.11 at $51.09.
